Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed Halawa

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Drugs in Context|April 20, 2023
Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcetMuhammed Ahmed Elhadedy, Ghada El-Kannishy, Ayman F Refaie, et al.
Renal Failure|May 20, 2020
Relationship between rabbit anti-thymocyte globulin and development of PTLD and its aggressive form in renal transplant populationHatem Ali, Karim Soliman, Ahmed Daoud, et al.
World Journal of Transplantation|October 30, 2018
Complement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in <i>de novo</i> and recurrent diseasesFedaey Abbas, Mohsen El Kossi, Jon Jin Kim, et al.
Clinical Kidney Journal|August 7, 2019
Implication of interleukin-2 receptor antibody induction therapy in standard risk renal transplant in the tacrolimus era: a meta-analysisHatem Ali, Atif Mohiuddin, Ajay Sharma, et al.
Therapeutic Advances in Respiratory Disease|October 24, 2009
Reduction of amiodarone pulmonary toxicity in patients treated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockersSemaan G Kosseifi, Ahmad Halawa, Ahmed Halawa, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|August 25, 2017
A Better Journey for Patients, a Better Deal for the NHS: The Successful Implementation of an Enhanced Recovery Program After Renal Transplant SurgeryAhmed Halawa, Stephen Rowe, Fleur Roberts, et al.
International Urology and Nephrology|March 15, 2020
Rabbit anti-thymocyte globulin (rATG) versus IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysisHatem Ali, Karim M Soliman, Ihab Shaheen, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Drugs in Context|April 20, 2023
Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcetMuhammed Ahmed Elhadedy, Ghada El-Kannishy, Ayman F Refaie, et al.
Renal Failure|May 20, 2020
Relationship between rabbit anti-thymocyte globulin and development of PTLD and its aggressive form in renal transplant populationHatem Ali, Karim Soliman, Ahmed Daoud, et al.
World Journal of Transplantation|October 30, 2018
Complement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in <i>de novo</i> and recurrent diseasesFedaey Abbas, Mohsen El Kossi, Jon Jin Kim, et al.
Clinical Kidney Journal|August 7, 2019
Implication of interleukin-2 receptor antibody induction therapy in standard risk renal transplant in the tacrolimus era: a meta-analysisHatem Ali, Atif Mohiuddin, Ajay Sharma, et al.
Therapeutic Advances in Respiratory Disease|October 24, 2009
Reduction of amiodarone pulmonary toxicity in patients treated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockersSemaan G Kosseifi, Ahmad Halawa, Ahmed Halawa, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|August 25, 2017
A Better Journey for Patients, a Better Deal for the NHS: The Successful Implementation of an Enhanced Recovery Program After Renal Transplant SurgeryAhmed Halawa, Stephen Rowe, Fleur Roberts, et al.
International Urology and Nephrology|March 15, 2020
Rabbit anti-thymocyte globulin (rATG) versus IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysisHatem Ali, Karim M Soliman, Ihab Shaheen, et al.
Pageof 6